|
|
|
|
|
|
|
Rexahn Pharmaceuticals Inc. (RNN)
|
|
1.71 -0.03 (-1.72%)
|
10-12 16:00
|
|
Open:
|
1.74
|
Pre. Close:
|
1.74
|
|
High:
|
1.7699
|
Low:
|
1.68
|
|
Volume:
|
53,452
|
Market Cap:
|
54M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.774 - 1.783
|
1.783 - 1.79
|
|
Low:
|
1.656 - 1.668
|
1.668 - 1.677
|
|
Close:
|
1.714 - 1.731
|
1.731 - 1.746
|
|
|
|
Technical analysis (as of: 2018-10-12 4:34:35 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 2.12  One year: 2.27
|
|
Support:
|
Support1: 1.62 Support2: 1.35
|
|
Resistance:
|
Resistance1:
1.82 Resistance2: 1.94
|
|
Pivot:
|
1.79
|
|
Moving Averages:
|
MA(5): 1.74 MA(20): 1.79
MA(100): 1.69 MA(250): 1.83
|
|
MACD:
|
MACD(12,26):
0.01 Signal(12,26,9): 0.03
|
|
%K %D:
|
%K(14,3): 24.14 %D(3): 24.90
|
|
RSI:
|
RSI(14): 47.99
|
|
52-Week:
|
High: 2.7
Low: 1.23 Change(%): -15.2
|
|
Average Vol(K):
|
3-Month: 12649
10-Days 11849
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.RNN has closed above bottom band by 18.4%. Bollinger Bands are 51.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to RNN's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-10-02T09:15:26-04:00
Rexahn Pharma's RX-3117 shows positive action in mid-stage pancreatic cancer study; shares up 4% premarket
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
